Public procurement notice: Additional Information
Published: 2016-07-30
Buyer: NHS Blood and Transplant
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33141000: Disposable medical supplies | 50421000
Submission deadline: 2016-08-15
Award criteria: The most economic tender

Technical requirements: UK-Bristol: Medicinske forbrugsvarer af ikke-kemisk natur til engangsbrug og hæmatologiske forbrugsvarer
The Blood Safety Quality Regulations (BSQR), set the minimum haemoglobin (Hb) levels for blood donors as 125 g/l or above for females and 135 g/l or above for males. NHSBT currently evaluate Hb levels of all donors immediately before each donation.
Donors are initially tested using a capillary blood sample and copper sulphate solution. If a donor fails this test a second, venous blood sample is taken and tested quantitatively in a HemoCue B device (on mobile sessions) or a HemoCue 201 (in donor centres).
It is estimated that approximately 350 Hb testing devices would be required (subject to final approval from NHSBT Board and availability of funds.) It is expected that an ‘off the peg’ Hb testing device model exists which will meet NHSBT criteria therefore the Hb Testing Devices project will adopt the traditional OJEU procurement process.
NHSBT's strategy is to deliver a modern world class service that is both efficient and productive. To achieve and sustain this strategic aim, NHSBT will expect manufacturers to work with them to align the capabilities of the Hb testing device to the improvements they make within the collection environment, throughout its life cycle.
The Blood Safety Quality Regulations (BSQR), set the minimum haemoglobin (Hb) levels for blood donors as 125 g/l or above for females and 135 g/l or above for males. NHSBT currently evaluate Hb levels of all donors immediately before each donation. Donors are initially tested using a capillary blood sample and copper sulphate solution. If a donor fails this test a second, venous blood sample is taken and tested quantitatively in a HemoCue 301 device on mobile sessions and donor centres. NHSBT wish to set up a framework for:
• Maintenance of its current HemoCue 301 devices (approximately 350) along with the supply of related consumables used for pre donation Hb testing
The Blood Safety Quality Regulations (BSQR), set the minimum haemoglobin (Hb) levels for blood donors as 125 g/l or above for females and 135 g/l or above for males. NHSBT currently evaluate Hb levels of all donors immediately before each donation.
Donors are initially tested using a capillary blood sample and copper sulphate solution. If a donor fails this test a second, venous blood sample is taken and tested quantitatively in a HemoCue B device (on mobile sessions) or a HemoCue 201 (in donor centres).
It is estimated that approximately 350 Hb testing devices would be required (subject to final approval from NHSBT Board and availability of funds.) It is expected that an ‘off the peg’ Hb testing device model exists which will meet NHSBT criteria therefore the Hb Testing Devices project will adopt the traditional OJEU procurement process.
NHSBT's strategy is to deliver a modern world class service that is both efficient and productive. To achieve and sustain this strategic aim, NHSBT will expect manufacturers to work with them to align the capabilities of the Hb testing device to the improvements they make within the collection environment, throughout its life cycle.
The Blood Safety Quality Regulations (BSQR), set the minimum haemoglobin (Hb) levels for blood donors as 125 g/l or above for females and 135 g/l or above for males. NHSBT currently evaluate Hb levels of all donors immediately before each donation. Donors are initially tested using a capillary blood sample and copper sulphate solution. If a donor fails this test a second, venous blood sample is taken and tested quantitatively in a HemoCue 301 device on mobile sessions and donor centres. NHSBT wish to set up a framework for:
• Maintenance of its current HemoCue 301 devices (approximately 350) along with the supply of related consumables used for pre donation Hb testing
The Blood Safety Quality Regulations (BSQR), set the minimum haemoglobin (Hb) levels for blood donors as 125 g/l or above for females and 135 g/l or above for males. NHSBT currently evaluate Hb levels of all donors immediately before each donation.
Donors are initially tested using a capillary blood sample and copper sulphate solution. If a donor fails this test a second, venous blood sample is taken and tested quantitatively in a HemoCue B device (on mobile sessions) or a HemoCue 201 (in donor centres).